Craig W. Day

2.0k total citations
30 papers, 1.5k citations indexed

About

Craig W. Day is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Craig W. Day has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 11 papers in Molecular Biology and 11 papers in Epidemiology. Recurrent topics in Craig W. Day's work include Influenza Virus Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Respiratory viral infections research (4 papers). Craig W. Day is often cited by papers focused on Influenza Virus Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Respiratory viral infections research (4 papers). Craig W. Day collaborates with scholars based in United States, Germany and China. Craig W. Day's co-authors include Donald F. Smee, Robert W. Sidwell, John D. Morrey, Dale L. Barnard, Kevin W. Bailey, Dale L. Barnard, Robert A. Montgomery, Justin G. Julander, Brett L. Hurst and Yohichi Kumaki and has published in prestigious journals such as Journal of the American Chemical Society, Biochemical and Biophysical Research Communications and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Craig W. Day

29 papers receiving 1.5k citations

Peers

Countries citing papers authored by Craig W. Day

Since Specialization

Citations

This map shows the geographic impact of Craig W. Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig W. Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig W. Day more than expected).

Fields of papers citing papers by Craig W. Day

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig W. Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig W. Day. The network helps show where Craig W. Day may publish in the future.

Co-authorship network of co-authors of Craig W. Day

This figure shows the co-authorship network connecting the top 25 collaborators of Craig W. Day. A scholar is included among the top collaborators of Craig W. Day based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig W. Day. Craig W. Day is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of a respiratory disease model for enterovirus D68 in 4-week-old mice for evaluation of antiviral therapies 2018 ·Antiviral Research ·(unknown), Brett L. Hurst, Christopher Peterson, Arnaud J. Van Wettere, Craig W. Day, Donald F. Smee, E. Bart Tarbet	26
2	Evaluation of cell viability dyes in antiviral assays with RNA viruses that exhibit different cytopathogenic properties 2017 ·Journal of Virological Methods ·Donald F. Smee, Brett L. Hurst, (unknown), (unknown), (unknown), Christopher Peterson, Kie‐Hoon Jung, Craig W. Day	49
3	A new oxygen modification cyclooctaoxygen binds to nucleic acids as sodium crown complex 2016 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·(unknown), Craig W. Day, (unknown), Raymond F. Schinazi	0
4	Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds 2016 ·Antiviral Research ·Donald F. Smee, (unknown), K. C. Nicolaou, E. Bart Tarbet, Craig W. Day	54
5	The Iminosugar UV-4 is a Broad Inhibitor of Influenza A and B Viruses ex Vivo and in Mice 2016 ·Viruses ·Kelly L. Warfield, Dale L. Barnard, Sven Enterlein, Donald F. Smee, Mansoora Khaliq, Aruna Sampath, Michael V. Callahan, Urban Ramstedt, Craig W. Day	34
6	Influenza Virus H1N1 inhibition by serine protease inhibitor (serpin) antithrombin III. 2014 ·PubMed ·Donald F. Smee, Brett L. Hurst, Craig W. Day, Ralf Geiben-Lynn	8
7	Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinones 2013 ·European Journal of Medicinal Chemistry ·Dmytro Havrylyuk, Borys Zimenkovsky, Olexandr Vasylenko, Craig W. Day, Donald F. Smee, Philippe Grellier, Roman Lesyk	88
8	Vaccine production training to develop the workforce of foreign institutions supported by the BARDA influenza vaccine capacity building program 2012 ·Vaccine ·E. Bart Tarbet, (unknown), Craig W. Day, (unknown)	5
9	Synthesis and Biological Evaluation of Epidithio-, Epitetrathio-, and bis-(Methylthio)diketopiperazines: Synthetic Methodology, Enantioselective Total Synthesis of Epicoccin G, 8,8′-epi-ent-Rostratin B, Gliotoxin, Gliotoxin G, Emethallicin E, and Haematocin and Discovery of New Antiviral and Antimalarial Agents 2012 ·Journal of the American Chemical Society ·K. C. Nicolaou, Min Lu, Sotirios Totokotsopoulos, Philipp Heretsch, Denis Giguère, Ya‐Ping Sun, David Šarlah, Thu‐Ha Nguyen, (unknown), Donald F. Smee, Craig W. Day, Selina Bopp, Elizabeth A. Winzeler	116
10	D282, a Non-Nucleoside Inhibitor of Influenza Virus Infection that Interferes with de novo Pyrimidine Biosynthesis 2012 ·Antiviral chemistry & chemotherapy ·Donald F. Smee, Brett L. Hurst, Craig W. Day	30
11	Antiviral Agents Derived from Novel 1-adamantyl Singlet Nitrenes 2012 ·Antiviral chemistry & chemotherapy ·(unknown), Hans‐Christoph Weiß, Andreas Schönleber, Craig W. Day, Dale L. Barnard, Mervi Detorio, Raymond F. Schinazi	6
12	In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections 2011 ·Antiviral Research ·Yohichi Kumaki, Craig W. Day, Donald F. Smee, John D. Morrey, Dale L. Barnard	31
13	(−)-Carbodine: Enantiomeric synthesis and in vitro antiviral activity against various strains of influenza virus including H5N1 (avian influenza) and novel 2009 H1N1 (swine flu) 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Ashok Kumar Jha, Ravindra K. Rawal, Ashoke Sharon, Craig W. Day, Dale L. Barnard, Donald F. Smee, Chung K. Chu	8
14	Targeting Robo4-Dependent Slit Signaling to Survive the Cytokine Storm in Sepsis and Influenza 2010 ·Science Translational Medicine ·Nyall R. London, Weiquan Zhu, Fernando A. Bozza, Matthew C. Smith, Daniel M. Greif, Lise K. Sorensen, Luming Chen, Yuuki Kaminoh, Aubrey C. Chan, Samuel F. Passi, Craig W. Day, Dale L. Barnard, Guy A. Zimmerman, Mark A. Krasnow, Dean Y. Li	267
15	A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo 2009 ·Virology ·Craig W. Day, Ralph S. Baric, Sui Xiong Cai, Matthew B. Frieman, Yohichi Kumaki, John D. Morrey, Donald F. Smee, Dale L. Barnard	118
16	Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? 2008 ·Antiviral Research ·Dale L. Barnard, Craig W. Day, Kevin W. Bailey, (unknown), Robert A. Montgomery, (unknown), (unknown), Joseph K.-K. Li, Paul K.S. Chan, Robert W. Sidwell	14
17	Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells 2008 ·Biochemical and Biophysical Research Communications ·Yohichi Kumaki, Craig W. Day, Miles K. Wandersee, (unknown), (unknown), (unknown), Jason Roth, Donald F. Smee, Lawrence M. Blatt, Dale L. Barnard	22
18	Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin 2006 ·Antiviral Research ·Dale L. Barnard, Craig W. Day, Kevin W. Bailey, (unknown), Robert A. Montgomery, (unknown), (unknown), Justin D. Hoopes, Joseph K.-K. Li, Jong‐Dae Lee, Dennis A. Carson, Howard B. Cottam, Robert W. Sidwell	85
19	Modeling hamsters for evaluating West Nile virus therapies 2004 ·Antiviral Research ·John D. Morrey, Craig W. Day, Justin G. Julander, Aaron L. Olsen, Robert W. Sidwell, Carl D. Cheney, Lawrence M. Blatt	36
20	Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increases dam survival 2004 ·Antiviral Research ·Justin G. Julander, Quinton A. Winger, Aaron L. Olsen, Craig W. Day, Robert W. Sidwell, John D. Morrey	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact